The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma

被引:101
|
作者
Rothhammer, T
Hahne, JC
Florin, A
Poser, I
Soncin, F
Wernert, N
Bosserhoff, AK
机构
[1] Univ Bonn, Inst Pathol, D-53127 Bonn, Germany
[2] Univ Regensburg, Inst Pathol, D-93042 Regensburg, Germany
[3] Inst Biol Lille, CNRS, UMR 8526, F-59021 Lille, France
关键词
malignant melanoma; Ets-1; proliferation; migration; invasion;
D O I
10.1007/s00018-003-3337-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Ets-1 transcription factor plays a role in tumor vascularization and invasion by regulating expression of matrix-degrading proteases in endothelial cells and fibroblasts in the tumor stroma. During early embryogenesis, Ets-1 is expressed in migrating neural crest cells from which melanocytes arise. In the present study, we analyzed Ets-1 expression in various melanocytic lesions and investigated its functional importance in malignant melanomas. We found that Ets-1 was upregulated both in vivo and in vitro in malignant melanoma, compared to benign melanocytic lesions and to primary melanocytes. Assessment of DNA-binding and transactivation assays documented a strong Ets activity in melanoma cells. Using an antisense strategy, the expression and activity of Ets-1 were reduced in the melanoma cell line Mel Im. This correlated with a diminished expression of several Ets-1 target genes known to be involved in invasion, such as MMP1, MMP3, uPA and integrin beta3. In line with these findings, the invasive potential of the melanoma cells measured in a Boyden Chamber model was reduced up to 60% after Ets-1 blockade. This can be attributed to the role of Ets-1 in transcriptional regulation of factors involved in invasion of melanoma cells. We conclude that over-expression of Ets-1 during melanoma development contributes to the malignant phenotype.
引用
收藏
页码:118 / 128
页数:11
相关论文
共 50 条
  • [1] The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma
    T. Rothhammer
    J. C. Hahne
    A. Florin
    I. Poser
    F. Soncin
    N. Wernert
    A.-K. Bosserhoff
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 118 - 128
  • [2] The Ets-1 transcription factor is involved in pterygial angiogenesis
    Naib-Majani, W.
    Breipohl, W.
    Shazli, E. E.
    Theuerkauf, I.
    Pleyer, U.
    Hahne, J. C.
    Wernert, N.
    ANATOMIA HISTOLOGIA EMBRYOLOGIA, 2007, 36 (02) : 107 - 110
  • [3] The ets-1 transcription factor is involved in pterygial angiogenesis
    Naib-Majani, Wallid
    Breipohl, Winrich
    Elshazli, Elham
    VIRCHOWS ARCHIV, 2007, 451 (02) : 459 - 460
  • [4] The transcription factor Ets-1 in breast cancer
    Lincoln, DW
    Bove, K
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 506 - 511
  • [5] Are mediated regulation of the transcription factor ETS-1
    Wilson, L
    Gemin, A
    Espiritu, R
    Singh, G
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 : S74 - S74
  • [6] ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma
    Spangler, Barbara
    Kappelmann, Melanie
    Schittek, Birgit
    Meierjohann, Svenja
    Vardimon, Lily
    Bosserhoff, Anja Katrin
    Kuphal, Silke
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (12) : 2801 - 2811
  • [7] Overexpression of Ets-1 transcription factor in angiosarcoma of the skin
    Naito, S
    Shimizu, K
    Nakashima, M
    Nakayama, T
    Ito, T
    Ito, M
    Yamashita, S
    Sekine, I
    PATHOLOGY RESEARCH AND PRACTICE, 2000, 196 (02) : 103 - 109
  • [8] Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation
    Z Ji
    C Degerny
    N Vintonenko
    J Deheuninck
    B Foveau
    C Leroy
    J Coll
    D Tulasne
    J-L Baert
    V Fafeur
    Oncogene, 2007, 26 : 395 - 406
  • [9] Role of the transcription factor Ets-1 in cisplatin resistance
    Wilson, LA
    Yamamoto, H
    Singh, G
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (07) : 823 - 832
  • [10] Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation
    Ji, Z.
    Degerny, C.
    Vintonenko, N.
    Deheuninck, J.
    Foveau, B.
    Leroy, C.
    Coll, J.
    Tulasne, D.
    Baert, J-L
    Fafeur, V.
    ONCOGENE, 2007, 26 (03) : 395 - 406